FTSE 100 slips as AstraZeneca drops on Bristol Myers merger talks

The UK's FTSE 100 index fell 0.10% to 10,857.49 points on Monday, driven by declines in AstraZeneca and energy heavyweights BP and Shell.

The UK's FTSE 100 ‌slipped on Monday as AstraZeneca shares fell on reports of a potential tie-up with U.S. drugmaker Bristol Myers Squibb, while lower oil prices dragged down energy heavyweights BP and Shell.

The blue-chip FTSE 100 index fell 0.10% to 10,857.49 points by ‌0931 GMT, while the mid-cap FTSE 250 rose nearly 1% to 24,206.25 points.